Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9273106 FGF mutants with reduced proteolysis and aggregation

Patent 9273106 was granted and assigned to Amgen on March, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11840558 Methods of treating non-alcoholic steatohepatitis using FGF21 mutants
0
Edits on 4 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 4 Dec, 2023
Edits made to:
Article (+154 characters)
Article

Patent abstract

The invention provides FGF21 mutant polypeptides with reduced proteolysis and aggregation, pharmaceutical compositions comprising the same.

Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0927310600
Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09273106 FGF mutants with reduced proteolysis and aggregation US Patent 9273106 FGF mutants with reduced proteolysis and aggregation

Infobox
Patent Number
0927310600
Patent Number
927310600
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Amgen
Amgen
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
092731060
Date of Patent
March 1, 2016
0
Patent Application Number
141344820
Date Filed
December 19, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=092731060
Patent Primary Examiner
‌
Christine J. Saoud
0
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Amgen
Amgen
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
092731060
Date of Patent
March 1, 2016
0
Patent Application Number
141344820
Date Filed
December 19, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=092731060
Patent Primary Examiner
‌
Christine J. Saoud
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09273106
Edits on 5 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 5 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09273106 FGF mutants with reduced proteolysis and aggregation

Infobox
Is a
Patent
Patent
Patent applicant
Amgen
Amgen
Current assignee
Amgen
Amgen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09273106
Date of patent
March 1, 2016
Patent application number
14134482
Date Filed
December 19, 2013
Patent primary examiner
‌
Christine J. Saoud

Find more entities like US Patent 9273106 FGF mutants with reduced proteolysis and aggregation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo